Exact Mass: 366.204228
Exact Mass Matches: 366.204228
Found 500 metabolites which its exact mass value is equals to given mass value 366.204228,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
dehydrocorydalin
C22H24NO4+ (366.17052440000003)
Dehydrocorydaline is an alkaloid. Dehydrocorydaline is a natural product found in Corydalis turtschaninovii, Corydalis nobilis, and other organisms with data available. Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\\%) using P. falciparum 3D7 strain[3]. Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\%) using P. falciparum 3D7 strain[3].
Hirsuteine
C22H26N2O3 (366.19433260000005)
Corynantheine is a monoterpenoid indole alkaloid. Corynantheine is a natural product found in Corynanthe pachyceras, Uncaria rhynchophylla, and other organisms with data available. Hirsuteine is an alkaloid. Hirsuteine is a natural product found in Uncaria tomentosa, Mitragyna hirsuta, and other organisms with data available. See also: Cats Claw (part of). Annotation level-1 Hirsuteine is an indole alkaloid extracted from Uncaria rhynchophylla. Hirsuteine non-competitively antagonizes nicotine-mediated dopamine release by blocking ion permeation through nicotinic receptor channel complexes[1].
Diacetoxyscirpenol
Diacetoxyscirpenol is a constituent of Fusarium species Mycotoxin D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins Constituent of Fusarium subspecies Mycotoxin C784 - Protein Synthesis Inhibitor D000970 - Antineoplastic Agents
20-Carboxy-leukotriene B4
20-Carboxyleukotriene B4 is an omega-oxidized metabolite of leukotriene B4 (LTB4). Neutrophil microsomes are known to oxidize 20-hydroxy-LTB4 (20-OH-LTB4) to its 20-oxo and 20-carboxy derivatives in the presence of NADPH. This activity has been ascribed to LTB4 omega-hydroxylase (cytochrome P-450LTB omega). Leukotriene B4 release from polymorphonuclear granulocytes of severely burned patients was reduced as compared to healthy donor cells. This decrease is due to an enhanced conversion of LTB4 into the 20-hydroxy- and 20-carboxy-metabolites and further to a decreased LTB4-synthesis. LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. Other specific pathways of leukotriene metabolism include the 12-hydroxydehydrogenase/ 15-oxo-prostaglandin-13-reductase that form a series of conjugated diene metabolites that have been observed to be excreted into human urine. Metabolism of LTC4 occurs by sequential peptide cleavage reactions involving a gamma-glutamyl transpeptidase that forms LTD4 (leukotriene D4) and a membrane-bound dipeptidase that converts LTD4 into LTE4 (leukotriene E4) before w-oxidation. These metabolic transformations of the primary leukotrienes are critical for termination of their biological activity, and defects in expression of participating enzymes may be involved in specific genetic disease. (PMID 17623009, 7633595, 2155225, 3039534)Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways.
2,2-Dimethyl-3-(4-methoxyphenyl)-4-propyl-2H-1-benzopyran-7-ol acetate
NCIOpen2_008600
C22H32F2O2 (366.23702359999993)
6alpha,9-Difluoro-11beta-hydroxyprogesterone
C21H28F2O3 (366.20064019999995)
Fortimicin KK1
An amino cyclitol glycoside that is (1R,2S,3S,4S,5S,6R)-2-amino-1,3,4,6-tetrahydroxy-5-(methylamino)cyclohexane in which the hydroxy group at position 1 is glycosylated by a heptapyranosyl residue.
Fumigaclavine C
An ergot alkaloid produced by the fungus Aspergillus fumigatus that is ergoline which is substituted by a 2-methylbut-3-en-2-yl group at position 2, methyl groups at the 6 and 8beta positions, and by an acetoxy group at the 9beta position.
17-(Trifluorovinyl)-3-(methyl ether)-17beta-estradiol
C21H25F3O2 (366.18065459999997)
Drospirenone
Drospirenone is a synthetic progestin that is an analog to spironolactone. It is found in a number of birth control formulations. Drospirenone differs from other synthetic progestins in that its pharmacological profile in preclinical studies shows it to be closer to the natural progesterone. As such it has anti-mineralocorticoid properties, counteracts the estrogen-stimulated activity of the renin-angiotensin-aldosterone system, and is not androgenic. G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AC - Progestogens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics
Umbelliprenin
Isolated from Angelica archangelica (angelica). Umbelliprenin is found in many foods, some of which are coriander, fats and oils, herbs and spices, and green vegetables. Umbelliprenin is found in coriander. Umbelliprenin is isolated from Angelica archangelica (angelica
Anhydrocinnzeylanol
Anhydrocinnzeylanol is found in chinese cinnamon. Anhydrocinnzeylanol is isolated from Cinnamomum cassia (Chinese cinnamon). Isolated from Cinnamomum cassia (Chinese cinnamon). Anhydrocinnzeylanol is found in chinese cinnamon and herbs and spices.
4-Acetyl-2-prenylphenol glucoside
4-Acetyl-2-prenylphenol glucoside is found in herbs and spices. 4-Acetyl-2-prenylphenol glucoside is a constituent of Helichrysum italicum (curry plant). Constituent of Helichrysum italicum (curry plant). 4-Acetyl-2-prenylphenol glucoside is found in tea and herbs and spices.
Sporotrichiol
Sporotrichiol is produced by Fusarium sporotrichioides. Production by Fusarium sporotrichioides
(1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside
(1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside is found in fats and oils. (1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside is a constituent of fruit of Carum carvi (caraway). Constituent of fruit of Carum carvi (caraway). (1S,2S,4R,8R)-p-Menthane-1,2,8,9-tetrol 2-glucoside is found in fats and oils and herbs and spices.
(1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside
(1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside is found in fats and oils. (1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside is a constituent of fruit of Carum carvi (caraway). Constituent of fruit of Carum carvi (caraway). (1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside is found in fats and oils and herbs and spices.
Bufotenine O-glucoside
Bufotenine O-glucoside is found in citrus. Bufotenine O-glucoside is an alkaloid from the leaves of Citrus unshiu (satsuma mandarin
Secoeremopetasitolide A
Secoeremopetasitolide A is found in green vegetables. Secoeremopetasitolide A is a constituent of Petasites japonicus (sweet coltsfoot). Constituent of Petasites japonicus (sweet coltsfoot). Secoeremopetasitolide A is found in green vegetables.
(2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside
(2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside is found in herbs and spices. (2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). (2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside is found in herbs and spices.
12-oxo-10,11-dihydro-20-COOH-LTB4
12-oxo-10,11-dihydro-20-COOH-LTB4 is formed when leukotriene B4 (LTB4) is metabolized by beta-oxidation. LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 8632343, 9667737). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 12-oxo-10,11-dihydro-20-COOH-LTB4 is formed when leukotriene B4 (LTB4) is metabolized by beta-oxidation. LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 8632343, 9667737)
12-oxo-20-dihydroxy-leukotriene B4
12-oxo-20-dihydroxy-leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region, and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by omega-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the omega-carboxy position and after CoA ester formation (PMID: 7649996, 17623009, 2853166, 6088485). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 12-oxo-20-dihydroxy-leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 7649996, 17623009, 2853166, 6088485)
7-Oxoprostaglandin I2
Corynantheine
C22H26N2O3 (366.19433260000005)
Fumigaclavine C
Geissoschizine methyl ether
C22H26N2O3 (366.19433260000005)
Gosogliptin
5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine
Linaprazan
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor
1-[2-[4-Methoxy-3-[3-(4-methoxyphenyl)propoxy]phenyl]ethyl]imidazole
C22H26N2O3 (366.19433260000005)
(Z)-7-[(1R,3S,4S,5R)-3-[(E,3R)-3-Hydroxyoct-1-enyl]-6-thiabicyclo[3.1.1]heptan-4-yl]hept-5-enoic acid
N,N-Diethyl-2-(2-(4-methoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide
Acetamide, 2-((2-hydroxyethyl)thio)-N-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)-
C19H30N2O3S (366.19770300000005)
1-[2-[4-Methoxy-2-[3-(4-methoxyphenyl)propoxy]phenyl]ethyl]imidazole
C22H26N2O3 (366.19433260000005)
9-(3-Imidazol-1-yl-2,6,6-trimethylcyclohexen-1-yl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
Britannin
Britannin, isolated from Inula aucheriana, is a sesquiterpene lactone. Britannin induces apoptosis and autophagy by activating AMPK regulated by ROS in liver cancer cells. Britannin has anti-proliferative and anti-inflammatory activities[1][2][3]. Britannin, isolated from Inula aucheriana, is a sesquiterpene lactone. Britannin induces apoptosis and autophagy by activating AMPK regulated by ROS in liver cancer cells. Britannin has anti-proliferative and anti-inflammatory activities[1][2][3].
Geissoschizine_methyl_ether
C22H26N2O3 (366.19433260000005)
Geissoschizine methyl ether is a natural product found in Uncaria rhynchophylla and Uncaria sinensis with data available. Geissoschizine methyl ether, a major indole alkaloid found in Uncaria hook, is a major active component of Yokukansan with psychotropic effects. Geissoschizine methyl ether is potent 5-HT1A receptor agonist[1][2]. Geissoschizine methyl ether, a major indole alkaloid found in Uncaria hook, is a major active component of Yokukansan with psychotropic effects. Geissoschizine methyl ether is potent 5-HT1A receptor agonist[1][2]. Geissoschizine methyl ether, a major indole alkaloid found in Uncaria hook, is a major active component of Yokukansan with psychotropic effects. Geissoschizine methyl ether is potent 5-HT1A receptor agonist[1][2].
Voachalotine
C22H26N2O3 (366.19433260000005)
A monoterpenoid indole alkaloid with formula C22H26N2O3, isolated from several Tabernaemontana species.
19,20-Didehydro-10-methoxytalcarpine
C22H26N2O3 (366.19433260000005)
3-Geranyl-2,4,6-trihydroxybenzophenone
A member of the class of benzophenones that is benzophenone substituted by a geranyl group at position 3 and hydroxy groups at positions 2, 4 and 6 respectively. Isolated from Leontonyx and Garcinia vieillardii, it exhibits a significant antileishmanial activity.
Dehydrocorydaline
C22H24NO4+ (366.17052440000003)
Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\\%) using P. falciparum 3D7 strain[3]. Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\%) using P. falciparum 3D7 strain[3].
Ohmefentanyl
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
2-{2-benzimidazol-2-yl-1-[(4-methylphenyl)methyl]ethyl}benzimidazole
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.970 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.968 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.963 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.961
Dicarboxyl-2But-A6EO4
Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); Could be alkyl homologue of given structure; Digitised from figure: approximate intensities
(+)-2-(1-hydroxy-4,4-dimethoxycyclohexyl)ethyl caffeate|2-(1-hydroxy-4,4-dimethoxycyclohexyl)ethyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate|mairine D
(1alpha,7alpha,14beta)-1,7,14,18,20-pentahydroxy-ent-kaur-16-en-15-one|1alpha,7alpha,14beta,18,20-pentahydroxy-ent-kaur-16-en-15-one|weisiensic C|weisiensin C
4-hydroxy-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]chromen-2-one
20-hydroxy-19-methylene-ibogamine-18-carboxylic acid methyl ester|Heyneanin
C22H26N2O3 (366.19433260000005)
[3-(3,7-dimethyl-2,6-octadienyl)-2,4,6-trihydroxyphenyl]phenylmethanone
Me glycoside,penta-Me-beta-Pyranose-3-O-beta-D-Xylopyranosyl-D-xylose
6alpha-hydroxyneopulchellin-4-O-<2-methyl butyrate>
rel-(1S,3R,5R,7Z,9R,12S,13S)-9-hydroperoxy-12-hydroxy-16-methylidene-5,9,13-trimethyl-4,14-dioxatricyclo[11.3.2.0(3,5)]octadec-7-en-15-one|snuladiterpene B
(+/-)-trans-3-(4-hydroxy-3-methoxyphenyl)-4-[(E)-3,4-dimethoxystyryl]cyclohex-1-ene
kopsifoline F|methyl (1R,4R,5R,13S,20S)-8-methoxy-6,16-diazahexacyclo[11.6.1.11.4.05.13.07.12.016.20]henicosa-7(12),8,10,18-tetraene-4-carboxylate
C22H26N2O3 (366.19433260000005)
6beta-Hydroxypulchellin 2-O-isovalerate|6beta-hydroxypulchellin-2-O-isovalerate
Hexa-Me-alpha-Pyranose-2-O-beta-D-Xylopyranosyl-D-xylose
7-oxo-12alpha,13beta,15-trihydroxyabiet-8(14)-en-18-oic acid
(13R,14R)-3,13,14,19-tetrahydroxy-ent-labda-8 (17),11-dien-16,15-olide
(Z)-4-hydroxy-3-(2-(6-hydroxy-5-(hydroxylmethyl)-5,8a-dimethyloctahydro-1H-spiro[naphthalene-2,2-oxiran]-1-yl)ethylidene)dihydrofuran-2(3H)-one
(E)-(2-(3,7-dimethylocta-2,6-dienyloxy)-4,6-dihydroxyphenyl)(phenyl)methanone|2-geranyloxy-4,6-dihydroxybenzophenone|elegaphenone
(3alpha,6beta,7alpha,8alpha,10alpha,15beta)-7,20-epoxykaur-16-ene-3,6,7,14,15-pentol|rabdonervosin G
15beta-methoxy-14,15-dihydroandranginine
C22H26N2O3 (366.19433260000005)
(1S,7S)-1,7,17-trihydroxy-15-oxo-ent-kauran-19-oic acid|geopyxin F
(3R,5R)-3-O-beta-D-mannosyl-3,5-dihydrodecanoic acid
7alpha,12alpha,14beta,18,20-pentahydroxy-ent-kaur-16-en-15-one|wikstroemioidin T
3alpha,7alpha,11beta,12alpha,14beta-pentahydroxy-ent-kaur-16-en-15-one|wikstroemioidin J
7,8,16,18-Tetrahydroxy-19-serrulatanoic acid|7,8,16,18-tetrahydroxyserrulatan-19-oic acid
3alpha,7alpha,12alpha,14beta,18-pentahydroxy-ent-kaur-16-en-15-one|wikstroemioidin K
11-methoxytabersonine
C22H26N2O3 (366.19433260000005)
The 16-methoxy derivative of tabersonine.
3-[3-hydroxy-4-(3-methylbut-2-enyl)phenyl]-5-(4-hydroxybenzyl)-4-methyldihydrofuran-2(3H)-one
ent-6beta,7beta-epoxy-1-methyl-2,3-didehydro-aspidospermidine-3-carboxylic acid methyl ester|Lochnerinin|N-methyl-lochnericine|N-methyl-tabersonine alpha-epoxide
C22H26N2O3 (366.19433260000005)
(ent-6beta,7alpha)-6,7,9-Trihydroxy-15-oxo-19-kauranoic acid
3,7-dimethyloct-3(10)-ene-1,2,6,7-tetrol 7-O-beta-D-glucopyranoside
(Z)-1,18-diisothiocyanooctadec-1-ene|1,2-Dihydro-(Z,Z)-1,18-Diisothiocyanato-1,17-octadecadiene
(1RS,3SR,5SR,8SR,9RS,13RS)-8,9-dihydroxy-5,9,13-trimethyl-16-methylidene-4,14-dioxatricyclo[11.3.2.0(3,5)]octadecane-12,15-dione|sinulaparvalide A
Methyl glycoside,penta-Me-beta-Pyranose -Xylobiose
7alpha,11beta,12alpha,14beta,20-pentahydroxy-ent-kaur-16-en-15-one|isolushinin J
6,7-seco-16xi,17-dihydroxy-6,7-dioxokaurenoic acid
6-<2-(2-hydroxy-4-methyl-5-isopropylphenyl)-ethyl>-7-methoxy-2,2-dimethylchromene|6-[2-(2-hydroxy-4-methyl-5-isopropylphenyl)-ethyl]-7-methoxy-2,2-dimethylchromene
(19E)-2xi-methoxy-(16alpha)-16,7-dihydro-2H-[1,4]oxazepino[4,5,6:1,2,16]-17-nor-cur-19-en-3-one|Tsilanin|Tsilanine
C22H26N2O3 (366.19433260000005)
12,15-sulfonyl-8(17),13-labdadien-19-oic acid
C20H30O4S (366.18647000000004)
2-Methyl-2-<4,4-dimethylpent-3-en-yl>-5,7-dihydroxy-6-benzoyl chroman
(2S,6zeta)-3,7-dimethyloct-3(10)-ene-1,2,6,7-tetrol 1-O-beta-D-glucopyranoside|(2S,6?卢)-3,7-Dimethyloct-3(10)-ene-1,2,6,7-tetrol 1-O-??-D-glucopyranoside
1beta-hydroxy-3alpha-(2-methylbutyryloxy)arbusculin A|1beta-hydroxy-3alpha-<2-methylbutyryloxy>arbusculin A
16,17-dihydro-16alpha,17-dihydroxy gibberellin A12
Ferulenol
Ferulenol is a natural product found in Ferula communis with data available. Ferulenol, a sesquiterpene prenylated coumarin derivative, specifically inhibits succinate ubiquinone reductase at the level of the ubiquinonecycle. Ferulenol shows good antimycobacterial activity and haemorrhagic action[1][2][3]. Ferulenol, a sesquiterpene prenylated coumarin derivative, specifically inhibits succinate ubiquinone reductase at the level of the ubiquinonecycle. Ferulenol shows good antimycobacterial activity and haemorrhagic action[1][2][3]. Ferulenol, a sesquiterpene prenylated coumarin derivative, specifically inhibits succinate ubiquinone reductase at the level of the ubiquinonecycle. Ferulenol shows good antimycobacterial activity and haemorrhagic action[1][2][3].
Dehydrocorydaline
[C22H24NO4]+ (366.17052440000003)
Annotation level-1 Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\\%) using P. falciparum 3D7 strain[3]. Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities[2]. Dehydrocorydaline shows strong anti-malarial effects (IC50=38 nM), and low cytotoxicity (cell viability?>?90\%) using P. falciparum 3D7 strain[3].
Drospirenone
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AC - Progestogens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics CONFIDENCE standard compound; INTERNAL_ID 2808 CONFIDENCE standard compound; INTERNAL_ID 8741
7-[(2E)-3,7-dimethylocta-2,6-dienoxy]-8-(3-methylbut-2-enyl)chromen-2-one
C20H30O6_2(5H)-Furanone, 5-hydroxy-3-[2-(octahydro-2,3-dihydroxy-5,6,8a-trimethylspiro[naphthalene-1(2H),2-oxiran]-5-yl)ethyl]
C20H30O6_2(5H)-Furanone, 5-hydroxy-4-[2-(octahydro-2,3-dihydroxy-5,6,8a-trimethylspiro[naphthalene-1(2H),2-oxiran]-5-yl)ethyl]
C23H30N2O2_Ergolin-9-ol, 2-(1,1-dimethyl-2-propen-1-yl)-6,8-dimethyl-, acetate (ester), (8alpha,9beta)
Tobramycin 1-N- or 3-N-carbamoyl, ion source fragment
3-[2-(6,7-dihydroxy-1,2,4a-trimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2-oxirane]-1-yl)ethyl]-2-hydroxy-2H-furan-5-one
4-[2-(6,7-dihydroxy-1,2,4a-trimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2-oxirane]-1-yl)ethyl]-2-hydroxy-2H-furan-5-one
7-[(2E)-3,7-dimethylocta-2,6-dienoxy]-8-(3-methylbut-2-enyl)chromen-2-one [IIN-based: Match]
4-[2-(6,7-dihydroxy-1,2,4a-trimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2-oxirane]-1-yl)ethyl]-2-hydroxy-2H-furan-5-one_major
3-[2-(6,7-dihydroxy-1,2,4a-trimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2-oxirane]-1-yl)ethyl]-2-hydroxy-2H-furan-5-one_major
3-[2-(6,7-dihydroxy-1,2,4a-trimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2-oxirane]-1-yl)ethyl]-2-hydroxy-2H-furan-5-one_4.1\\%
4-[2-(6,7-dihydroxy-1,2,4a-trimethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2-oxirane]-1-yl)ethyl]-2-hydroxy-2H-furan-5-one_minor
Gly Pro Pro Pro
C17H26N4O5 (366.19031060000003)
Pro Gly Pro Pro
C17H26N4O5 (366.19031060000003)
Pro Pro Gly Pro
C17H26N4O5 (366.19031060000003)
Pro Pro Pro Gly
C17H26N4O5 (366.19031060000003)
SKF-96365
C22H26N2O3 (366.19433260000005)
Bufotenine O-glucoside
(2R,6x)-7-Methyl-3-methylene-1,2,6,7-octanetetrol 2-glucoside
Anhydrocinnzeylanol
Sporotrichiol
(1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside
(1R*,2R*,4R*,8S*)-p-Menthane-1,2,8,9-tetrol 9-glucoside
JWH 018 2-hydroxyindole metabolite-d9
C24H14D9NO2 (366.22936440200004)
JWH 018 4-hydroxyindole metabolite-d9
C24H14D9NO2 (366.22936440200004)
JWH 018 5-hydroxyindole metabolite-d9
C24H14D9NO2 (366.22936440200004)
JWH 018 6-hydroxyindole metabolite-d9
C24H14D9NO2 (366.22936440200004)
JWH 018 7-hydroxyindole metabolite-d9
C24H14D9NO2 (366.22936440200004)
(S)-ETHYL 2-(((S)-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPIN-3-YL)AMINO)-4-PHENYLBUTANOATE
C22H26N2O3 (366.19433260000005)
4-(1-HYDROXY-1-(3,5,5,8,8-PENTAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)ETHYL)BENZOIC ACID
1-benzyl-4-(N-propanoylanilino)piperidine-4-carboxylic acid
C22H26N2O3 (366.19433260000005)
1-Benzyl-4-[N-(1-propanoyl)-N-phenylamino]-4-methoxymethylpiperidine
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclopentyl-N-(4-fluorophenyl)- (9CI)
C21H23FN4O (366.18557999999996)
2,2-(2,5-Difluoro-1,4-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
1,3-diisocyanato-2-methylbenzene,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,2-methyloxirane
hexanedioic acid,2-(2-hydroxyethoxy)ethanol,oxepan-2-one
(S)-TERT-BUTYL2-(HYDRAZINECARBONYL)PYRROLIDINE-1-CARBOXYLATE
4,5-diisocyanatobicyclo[4.1.0]hepta-1(6),2,4-triene,ethane-1,2-diamine,2-methyloxirane,propane-1,2-diol
C17H26N4O5 (366.19031060000003)
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclopentyl-N-(2-fluorophenyl)- (9CI)
C21H23FN4O (366.18557999999996)
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclopentyl-N-(3-fluorophenyl)- (9CI)
C21H23FN4O (366.18557999999996)
Methylatropine nitrate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-[(4-methylphenyl)methyl]-N-propyl- (9CI)
C21H26N4S (366.18780760000004)
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-(2-methylpropyl)-N-(phenylmethyl)- (9CI)
C21H26N4S (366.18780760000004)
N-ETHYL-N-PYRIDIN-4-YLMETHYL-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE
4-Ethoxyphenyl 4-trans-(4-propylcyclohexyl)benzoate
ethyl 3-undecylthieno[3,2-b]thiophene-2-carboxylate
C20H30O2S2 (366.16871199999997)
N-METHYL-N-(2-PYRIDIN-2-YL-ETHYL)-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE
2-Benzyl-2-(dimethylamino)-4-morpholinobutyrophenone
Gosogliptin
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Liafensine
C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor
3-Cinnolinecarboxamide, 4-amino-8-(2,5-dimethoxyphenyl)-N-propyl-
Roluperidone
C22H23FN2O2 (366.17434699999995)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
N-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide
1-(5-Oxo-2,3,5,9B-tetrahydro-1H-pyrrolo[2,1-A]isoindol-9-YL)-3-(5-pyrrolidin-2-YL-1H-pyrazol-3-YL)-urea
C19H22N6O2 (366.18041519999997)
Acetamide, 2-((2-hydroxyethyl)thio)-N-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)-
C19H30N2O3S (366.19770300000005)
2-(3,3-dimethyl-1-oxo-4,9-dihydro-2H-xanthen-9-yl)-5,5-dimethylcyclohexane-1,3-dione
L 152804 is an orally active and selective neuropeptide Y Y5 receptor (NPY5-R) antagonist, with a Ki of 26 nM for hY5. L 152804 causes weight loss in diet-induced obese mice by modulating food intake and energy expenditure[1][2].
SKF-96365 free base
C22H26N2O3 (366.19433260000005)
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
8-(4-aminophenyl)-5-methyl-N-propyl-5H-[1,3]dioxolo[4,5-g]phthalazine-6-carboxamide
SYM2206 is a potent and non-competitive AMPA receptor antagonist, with an IC50 of 1.6 μM. SYM2206 blocks Nav1.6-mediated persistent currents[1][2].
6alpha,9-Difluoro-11beta-hydroxy progesterone
C21H28F2O3 (366.20064019999995)
2alpha,3alpha-(Difluoromethylene)-5alpha-androstan-17beta-ol, acetate
C22H32F2O2 (366.23702359999993)
20,21,21-Trifluoro-3-methoxy-19-nor-17alpha-pregna-1,3,5(10),20-tetraen-17-ol
C21H25F3O2 (366.18065459999997)
7-((2E)-3,7-Dimethylocta-2,6-dienoxy)-8-(3-methylbut-2-enyl)chromen-2-one
4-(6-Cyclohexylmethoxy-9H-purin-2-ylamino)--benzamide
C19H22N6O2 (366.18041519999997)
3-[2-(2,3-dihydroxy-5,6,8a-trimethyloctahydro-2H-spiro[naphthalene-1,2-oxiran]-5-yl)ethyl]-5-hydroxyfuran-2(5H)-one
alpha,alpha-Dihydro-3,5,4-trihydroxy-4,5-diisopentenylstilbene
2,4-Bis(3-methyl-2-butenyl)-5-(4-hydroxyphenethyl)resorcinol
1-Tetradecylglycerone 3-phosphate
C17H35O6P (366.21711400000004)
A 1-alkylglycerone 3-phosphate in which the alkyl group is specified as tetradecyl
(1R,2S,3S,4R,8S,9S,12R,13R)-13-hydroxy-13-(hydroxymethyl)-4,8-dimethyltetracyclo[10.2.1.01,9.03,8]pentadecane-2,4-dicarboxylic acid
methyl (Z)-2-(3-ethenyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate
C22H26N2O3 (366.19433260000005)
methyl (Z)-2-[(3Z)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate
C22H26N2O3 (366.19433260000005)
(Z)-7-[(1R,3S,4S,5R)-3-[(E,3R)-3-Hydroxyoct-1-enyl]-6-thiabicyclo[3.1.1]heptan-4-yl]hept-5-enoic acid
(6E,8E,10E,14E)-5,12-dihydroxyicosa-6,8,10,14-tetraenedioic acid
(5E)-5-[5-hydroxy-4-[(E)-3-hydroxyoct-1-enyl]-3-oxo-4,5,6,6a-tetrahydro-3aH-cyclopenta[b]furan-2-ylidene]pentanoic acid
5,5-diethyl-1-[oxo(1-piperidinyl)methyl]-6H-pyrrolo[2,1-a]isoquinoline-2,3-dione
C22H26N2O3 (366.19433260000005)
1-hydroxy-5-nitro-N-(2-phenylethyl)-4-spiro[benzimidazole-2,1-cyclohexane]imine
[2-(3-Fluorophenyl)-5-propyl-pyrazol-3-yl] 2-phenylbutanoate
C22H23FN2O2 (366.17434699999995)
2-ethyl-N-[1-[2-(1-piperidinyl)ethyl]-2-benzimidazolyl]-3-pyrazolecarboxamide
N4-(2-furanylmethyl)-N2-(3-methylphenyl)-6-(4-morpholinyl)-1,3,5-triazine-2,4-diamine
C19H22N6O2 (366.18041519999997)
Methyl (12S,14S,15E)-15-ethylidene-13-(hydroxymethyl)-3-methyl-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraene-13-carboxylate
C22H26N2O3 (366.19433260000005)
Sarpagan-16-carboxylic acid, 17-hydroxy-1-methyl-, methyl ester, (16R)-
C22H26N2O3 (366.19433260000005)
1-(4-Methyl-2-prop-2-enylphenoxy)-3-(4-phenyl-1-piperazinyl)-2-propanol
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(3-methylpiperidin-1-yl)-2-phenylacetamide
C22H26N2O3 (366.19433260000005)
methyl (9S,10S,12S,13E,16S,18S)-13-ethylidene-18-hydroxy-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-17-carboxylate
C22H26N2O3 (366.19433260000005)
(E)-N-cyclohexyl-3-(3,4-dimethoxyphenyl)-N-pyridin-2-ylprop-2-enamide
C22H26N2O3 (366.19433260000005)
(5Z,9S,11R,13E,15S,17Z)-15-hydroperoxy-9,11-epidioxyprosta-5,13,17-trienoic acid
(4-Fluorophenyl)-[4-(4-phenylcyclohexyl)-1-piperazinyl]methanone
4-[3-(1-Naphthalenyl)prop-2-ynyl]-4-(3-phenylprop-2-ynyl)morpholin-4-ium
(1R,2aR,8bR)-1-(hydroxymethyl)-N-propan-2-yl-2-(2-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1R,2aS,8bS)-1-(hydroxymethyl)-N-propan-2-yl-2-(2-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1S,2aR,8bR)-1-(hydroxymethyl)-N-propan-2-yl-2-(2-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1S,2aS,8bS)-1-(hydroxymethyl)-N-propan-2-yl-2-(2-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
[(2S,3R)-6-(cyclopropylmethyl)-1-[(4-fluorophenyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol
[(3aR,4R,9bR)-4-(hydroxymethyl)-8-[(E)-prop-1-enyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-fluorophenyl)methanone
C22H23FN2O2 (366.17434699999995)
(2R,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-[4-oxanyl(oxo)methyl]-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2R,3S,4R)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxyacetyl)azetidine-2-carbonitrile
C22H26N2O3 (366.19433260000005)
(2S,3S,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-[4-oxanyl(oxo)methyl]-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2R,3R,4S)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2S,3R,4S)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2R,3S,4S)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2R,3R,4R)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2R,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-[4-oxanyl(oxo)methyl]-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2S,3S,4S)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
(2S,3S,4R)-3-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-azetidinecarbonitrile
C22H26N2O3 (366.19433260000005)
1-[(3aR,4S,9bS)-4-(hydroxymethyl)-5-methyl-8-pent-1-ynyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-cyclopropylethanone
N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-[4-(5-pyrimidinyl)phenyl]-2-azetidinyl]methyl]cyclopentanecarboxamide
1-[(2S,3R)-2-(hydroxymethyl)-6-[oxo(2-pyrazinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-1-propanone
1-[(2R,3R)-2-(hydroxymethyl)-3-phenyl-6-(phenylmethyl)-1,6-diazaspiro[3.3]heptan-1-yl]-2-methoxyethanone
C22H26N2O3 (366.19433260000005)
methyl 8-[(2E)-2-[(4-hydroxy-2,6-dimethoxyphenyl)methylidene]hydrazinyl]-8-oxooctanoate
2-(4-benzylpiperazin-1-yl)-N-[(E)-[(Z)-3-(furan-2-yl)-2-methylprop-2-enylidene]amino]acetamide
methyl (1R,16R,18R,21S)-2-methyl-11-oxo-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate
C22H26N2O3 (366.19433260000005)
3-[3-(Ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]propanoic acid
C22H26N2O3 (366.19433260000005)
methyl (1S,9S,14E,16R)-14-ethylidene-2-methyl-18-oxa-2,12-diazahexacyclo[13.3.2.01,9.03,8.09,16.012,19]icosa-3,5,7-triene-16-carboxylate
C22H26N2O3 (366.19433260000005)
(1R,4E,6R,7R,17S)-4-Ethylidene-7,17-dihydroxy-6,7,14-trimethyl-2,9-dioxa-14-azoniatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione
C19H28NO6+ (366.19165280000004)
(1R,2R,4R,10R,11R,14S,15R,16S,18S,19S)-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadec-5-ene-15,5-oxolane]-2,7-dione
(2-hydroxy-3-phosphonooxypropyl) (Z)-tridec-9-enoate
[(E)-2-acetamido-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
(2S,3S)-3-Benzyloxy-4-(tert-butyldimethylsilyloxy)butan-1,2-diol isopropylidene acetal
C20H34O4Si (366.22262440000003)
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-(2-aminoethoxy)-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
[(6Ar,9R,10S,10aR)-7,9-dimethyl-5-(2-methylbut-3-en-2-yl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-10-yl] acetate
(5R,6Z,8E,14Z)-5-hydroxy-12-oxoicosa-6,8,14-trienedioic acid
Methyl 2-(3-ethenyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate
C22H26N2O3 (366.19433260000005)
2alpha,3alpha-(Difluoromethylene)-5alpha-androstan-17beta-ol acetate
C22H32F2O2 (366.23702359999993)
20-hydroxy-20-oxoleukotriene B4
A member of the class of leukotrienes that is leukotriene B4 in which the terminal methyl group has undergone formal oxidation to the corresponding carboxylic acid.
(1s,2s,5s,7r,8r,9s,10s,11r,15s)-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-7,9,10,15,18-pentol
(1s,2s,5s,7r,8s,9s,10s,11r,15s,18r)-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-7,9,10,15,18-pentol
(1s,2r,5r,6s,10r,12r,13s,14r)-1,6,14-trihydroxy-13-(hydroxymethyl)-8-isopropyl-2,5-dimethyl-15-oxatetracyclo[10.2.1.0²,¹⁰.0⁵,⁹]pentadec-8-en-7-one
(1s,2s,5s,7r,9s,10s,11r,15s,18r)-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-7,9,10,15,18-pentol
methyl (15e)-15-ethylidene-13-(hydroxymethyl)-3-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraene-13-carboxylate
C22H26N2O3 (366.19433260000005)
12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-7,9,10,15,18-pentol
(3as,6r,10s,11r,11as)-10-hydroxy-6,10-dimethyl-3-methylidene-2,5-dioxo-octahydrocyclodeca[b]furan-11-yl (2r)-2-methylbutanoate
(1s,2s,3r,5s,8r,9r,10r)-1,2,5,9,10-pentahydroxy-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-13-one
(1s,2r,4ar,8ar)-7-(2-hydroperoxypropan-2-yl)-1-hydroxy-1,4a-dimethyl-6-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl (2z)-2-methylbut-2-enoate
(1r,2r,4r,5s,9s,10s,12s,13r,16r)-2,12,16-trihydroxy-5,9-bis(hydroxymethyl)-5-methyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one
(1r,2r,4s,5s,9r,10s,11r,12r,13s,16r)-2,11,12,16-tetrahydroxy-5-(hydroxymethyl)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one
(3r,5r,9s,12e,14s)-14-ethyl-5-hydroxy-5-(hydroxymethyl)-3,9,13-trimethyl-11-methylidene-1-oxacyclotetradec-12-ene-2,4,7-trione
(1r,2s,4r,4ar,5r,6r,8s,8as)-5-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-5,6,8a-trimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxirane]-2,4,8-triol
4-{2-[(1s,3as,4r,6as,7r,8s,10as)-1,3a,4-trihydroxy-7,8-dimethyl-octahydro-1h-naphtho[4,4a-c]furan-7-yl]ethyl}-5h-furan-2-one
(1s,2s,3r,5s,7r,8s,9s,10s,11r,15s)-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,15-pentol
3-[3-hydroxy-4-(3-methylbut-2-en-1-yl)phenyl]-5-[(4-hydroxyphenyl)methyl]-4-methyloxolan-2-one
(3r,5r)-5-hydroxy-3-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}decanoic acid
5,13-dihydroxy-4,8,13-trimethyltetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadecane-2,4-dicarboxylic acid
(2s,3r,4s,7r)-4,6-dimethyl-10-(2-methylbut-3-en-2-yl)-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate
(1r,2s,5s,7s,11s,12r,13s)-2-hydroxy-16-(hydroxymethyl)-2,7,11-trimethyl-6,14,19-trioxatetracyclo[10.6.1.0⁵,⁷.0¹³,¹⁷]nonadec-16-en-15-one
(1ar,2s,4ar,7r,7ar,7br)-7-hydroxy-1,1,7-trimethyl-4-methylidene-octahydrocyclopropa[e]azulen-2-yl (2e)-3-phenylprop-2-enoate
1,4a-dimethyl-5-[(3-methyl-1,1-dioxo-2,5-dihydro-1λ⁶-thiophen-2-yl)methyl]-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
C20H30O4S (366.18647000000004)
(2r,3s,5s)-2-{[(6s)-6,7-dihydroxy-3,7-dimethyloct-1-en-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,4,5-tetrol
methyl (1s,12s,13s,14r,15e)-15-ethylidene-7-methoxy-3-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraene-13-carboxylate
C22H26N2O3 (366.19433260000005)
4,9a-dihydroxy-3,5a-dimethyl-9-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-6-yl 3-methylbutanoate
(1r,3s,5s,7z,9s,12s,13r)-9-hydroperoxy-12-hydroxy-5,9,13-trimethyl-16-methylidene-4,14-dioxatricyclo[11.3.2.0³,⁵]octadec-7-en-15-one
[(3ar,4as,5s,7s,7as,8r,9as)-5,7-dihydroxy-8-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-4a-yl]methyl 3-methylbutanoate
methyl (1r,9r,15r,16s,19r)-14-ethylidene-2-methyl-18-oxa-2,12-diazahexacyclo[13.3.2.0¹,⁹.0³,⁸.0⁹,¹⁶.0¹²,¹⁹]icosa-3,5,7-triene-16-carboxylate
C22H26N2O3 (366.19433260000005)
(1s,4r,5s,9s,10r,12s)-16-(2-hydroperoxypropan-2-yl)-5,9-dimethyl-13,14-dioxatetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadec-15-ene-5-carboxylic acid
6,9a-dihydroxy-3,5a-dimethyl-9-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-4-yl 3-methylbutanoate
4-{1-hydroxy-2-[8-hydroxy-8a-(hydroxymethyl)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]ethyl}-5h-furan-2-one
(3e,4s)-3-{2-[(1r,2r,4r,4ar,6s,8as)-4,6-dihydroxy-5,5,8a-trimethyl-hexahydro-1h-spiro[naphthalene-2,2'-oxiran]-1-yl]ethylidene}-4-hydroxyoxolan-2-one
4-(formyloxy)-2,5,5,8a-tetramethyl-5'-oxo-hexahydro-2h-spiro[naphthalene-1,2'-oxolan]-6-yl acetate
1-[(1s,12s,13r,18r)-6-methoxy-3,20-dimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8,16-pentaen-17-yl]ethanone
C22H26N2O3 (366.19433260000005)
4-benzoyl-5-[(3,7-dimethylocta-2,6-dien-1-yl)oxy]benzene-1,3-diol
(1r,2r,4s,6r,9r,10s,11r,12r,13s,16r)-2,6,11,12,16-pentahydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one
methyl (1s,9s,10r,13r,20s)-5-methoxy-8,17-diazahexacyclo[11.6.1.1¹⁰,¹³.0¹,⁹.0²,⁷.0¹⁷,²⁰]henicosa-2,4,6,14-tetraene-10-carboxylate
C22H26N2O3 (366.19433260000005)
(1s,3as,4s,6r)-7-[(2s,4r)-4-hydroxy-5-oxooxolan-2-yl]-1-(hydroxymethyl)-1,3,3,6-tetramethyl-3a,4,5,6-tetrahydro-2h-inden-4-yl acetate
5-[(1r,6r)-6-[(1e)-2-(1h-indol-5-yl)ethenyl]-3,6-dimethylcyclohex-2-en-1-yl]-1h-indole
1-{6-methoxy-3,20-dimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8,16-pentaen-17-yl}ethanone
C22H26N2O3 (366.19433260000005)
11-hydroxy-6-(hydroxymethyl)-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,6h,7h,8h,11h,11ah-cyclodeca[b]furan-4-yl 2-methylbutanoate
(4r,9r,10r,12r,13r,14r)-10,12,13,14-tetrahydroxy-5,5,9-trimethyl-11-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carbaldehyde
(1s,4ar,5s,8ar)-1,4a-dimethyl-5-{[(2r)-3-methyl-1,1-dioxo-2,5-dihydro-1λ⁶-thiophen-2-yl]methyl}-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
C20H30O4S (366.18647000000004)
methyl 14-ethylidene-2-methyl-18-oxa-2,12-diazahexacyclo[13.3.2.0¹,⁹.0³,⁸.0⁹,¹⁶.0¹²,¹⁹]icosa-3,5,7-triene-16-carboxylate
C22H26N2O3 (366.19433260000005)
(3ar,5s,6s,15s,15ar)-5,6,15-trihydroxy-6-(hydroxymethyl)-10,14-dimethyl-3-methylidene-3ah,4h,5h,7h,8h,11h,12h,15h,15ah-cyclotetradeca[b]furan-2-one
(1r,2s,4ar,8ar)-7-(2-hydroperoxypropan-2-yl)-1-hydroxy-1,4a-dimethyl-6-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl (2z)-2-methylbut-2-enoate
2-benzoyl-4-[(1r,4r)-2,2-dimethyl-4-(prop-1-en-2-yl)cyclopentyl]benzene-1,3,5-triol
(2r,4ar,7r,8s,8ar)-8-hydroxy-3',3',4a,8-tetramethyl-3-oxo-hexahydrospiro[naphthalene-2,2'-oxiran]-7-yl (2s,3s)-2,3-dimethyloxirane-2-carboxylate
(6r,8s)-6-ethoxy-5-methoxy-2,2-dimethyl-8-phenyl-6h,7h,8h-pyrano[3,2-g]chromene
5,6,15-trihydroxy-6-(hydroxymethyl)-10,14-dimethyl-3-methylidene-3ah,4h,5h,7h,8h,11h,12h,15h,15ah-cyclotetradeca[b]furan-2-one
(3e,4s)-3-{2-[(1r,2s,4r,4ar,6s,8as)-4,6-dihydroxy-5,5,8a-trimethyl-hexahydro-1h-spiro[naphthalene-2,2'-oxiran]-1-yl]ethylidene}-4-hydroxyoxolan-2-one
(5s)-4-{2-[(1r,2r,3r,4as,8as)-1,3-dihydroxy-2,5,5,8a-tetramethyl-4-oxo-hexahydronaphthalen-1-yl]ethyl}-5-hydroxy-5h-furan-2-one
7-[(1,1,3a,5-tetramethyl-2-oxo-3,4,7,7a-tetrahydroinden-4-yl)methoxy]chromen-2-one
2-hydroxy-3-[(6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]chromen-4-one
methyl (2e)-2-[(2r,3r,12br)-3-ethenyl-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate
C22H26N2O3 (366.19433260000005)
2,8,16-trihydroxy-5,9-bis(hydroxymethyl)-5-methyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one
(1s,12s,13r,18r)-7-methoxy-3,16,20-trimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8,16-pentaene-17-carbaldehyde
C22H26N2O3 (366.19433260000005)
6-[(1e)-2-[(5r,7r)-5-methyl-7-(2-methylprop-1-en-1-yl)-1h,6h,7h-cyclopenta[f]indol-5-yl]ethenyl]-1h-indole
methyl (1r,9r,14e,15r,16s,19r)-14-ethylidene-2-methyl-18-oxa-2,12-diazahexacyclo[13.3.2.0¹,⁹.0³,⁸.0⁹,¹⁶.0¹²,¹⁹]icosa-3,5,7-triene-16-carboxylate
C22H26N2O3 (366.19433260000005)
8-hydroxy-3',3',4a,8-tetramethyl-3-oxo-hexahydrospiro[naphthalene-2,2'-oxiran]-7-yl 2,3-dimethyloxirane-2-carboxylate
1-hydroxy-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-6-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl 2,3-dimethyloxirane-2-carboxylate
4-{2-[(1r,3as,4r,6as,7r,8s,10as)-1,3a,4-trihydroxy-7,8-dimethyl-octahydro-1h-naphtho[1,8a-c]furan-7-yl]ethyl}-5h-furan-2-one
(3ar,6s,10r,11s,11ar)-10-hydroxy-6,10-dimethyl-3-methylidene-2,5-dioxo-octahydrocyclodeca[b]furan-11-yl (2r)-2-methylbutanoate
methyl (1r,9s,10s,12s,13e)-13-ethylidene-18-hydroxy-8-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-triene-17-carboxylate
C22H26N2O3 (366.19433260000005)